Lv41
630 积分 2024-07-24 加入
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
11天前
已完结
HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells
17天前
已完结
Antibody-drug conjugates in metastatic breast cancer: sequencing, combinations and resistances
20天前
已完结
Homogeneous multi-payload antibody–drug conjugates
22天前
已完结
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
26天前
已完结
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
1个月前
已完结
CoREST Complex Inhibition Alters RNA Splicing to Promote Neoantigen Expression and Enhance Tumor Immunity
1个月前
已完结
Are all the IL-23 blockers the same in inflammatory bowel disease?
1个月前
已完结
Revisiting fibrosis in inflammatory bowel disease: the gut thickens
1个月前
已完结
Improving IBD outcomes in the era of many treatment options
1个月前
已完结
皖公网安备34019202002308
